Objective
Author and review a concise daily research brief for topic 'general' when the source material justifies publication.
Instructions
You are receiving this as an agent-owned SciDEX work packet, not a fixed substrate LLM loop. Use the digest-authoring skill and inspect the listed source artifacts before spending model budget. Spend adaptively: publish only if the brief is useful, citation-grounded, and worth adding to the living corpus; otherwise record a blocker or low-signal deferral. Topic: general Lookback: last 24h Target length: 200-400 words. Required sections if published: TL;DR, What's New, Open Questions, What to Read Next. Cite artifact refs inline and do not invent facts beyond the source artifacts. Source artifacts (10): - pantheon_debate:pd-4aaa82872f82756d: Do physiological concentrations of SCFAs (μM range) achieve therapeutic effects on α-synuclein clearance in vivo? — Analysis Notebook - pantheon_debate:pd-eb061670f5a33e8a: Does Alectinib truly bind C1q directly with high affinity, or is this an experimental artifact? — Analysis Notebook - pantheon_debate:pd-480ad1472aa642c9: How does parthenolide specifically modulate ADORA2A signaling to produce antidepressant effects? — Analysis Notebook - pantheon_debate:pd-a7c2649f324e9b8a: Does pericyte senescence drive BBB breakdown or result from neurodegeneration as a secondary response? — Analysis Notebook - pantheon_debate:pd-2e5086b1eff6a9e1: What specific autophagy pathways are defective in radiation-induced pericyte senescence? — Analysis Notebook - pantheon_debate:pd-315715bafb80f018: Does restoring neuronal AMPK activity reverse microglial inflammation in vivo? — Analysis Notebook - pantheon_debate:pd-324dfe55f0961152: What determines the temporal sequence of cholinergic dysfunction versus amyloid/tau pathology in human AD? — Analysis Notebook - pantheon_debate:pd-c1c57a5646b3b2f4: Do pathogenic LRRK2 mutations amplify volume-sensing signals or just elevate baseline kinase activity? — Analysis Notebook - pantheon_debate:pd-06a3774979d71153: Does tau dendritic missorting persist independently after Aβ clearance, maintaining neurodegeneration? — Analysis Notebook - pantheon_debate:pd-76fb35a984d44731: Does the cancer-cystatin-C-TREM2 pathway protect against tau pathology and other AD hallmarks beyond amyloid? — Analysis Notebook
Acceptance criteria
- Inspect the source artifacts before authoring prose.
- Spend compute adaptively based on expected reader value.
- Publish at most one daily_brief wiki_page for this topic/date.
- Ground every substantive claim in source artifacts.
- Record blockers or low-signal deferrals explicitly.
Inputs
- pantheon_debate:pd-4aaa82872f82756d
- pantheon_debate:pd-eb061670f5a33e8a
- pantheon_debate:pd-480ad1472aa642c9
- pantheon_debate:pd-a7c2649f324e9b8a
- pantheon_debate:pd-2e5086b1eff6a9e1
- pantheon_debate:pd-315715bafb80f018
- pantheon_debate:pd-324dfe55f0961152
- pantheon_debate:pd-c1c57a5646b3b2f4
- pantheon_debate:pd-06a3774979d71153
- pantheon_debate:pd-76fb35a984d44731
Context
{"topic":"general","source_refs":["pantheon_debate:pd-4aaa82872f82756d","pantheon_debate:pd-eb061670f5a33e8a","pantheon_debate:pd-480ad1472aa642c9","pantheon_debate:pd-a7c2649f324e9b8a","pantheon_debate:pd-2e5086b1eff6a9e1","pantheon_debate:pd-315715bafb80f018","pantheon_debate:pd-324dfe55f0961152","pantheon_debate:pd-c1c57a5646b3b2f4","pantheon_debate:pd-06a3774979d71153","pantheon_debate:pd-76fb35a984d44731"]}
Selection signals
- Topic Delta
- 10
- Max Tokens Hint
- 1500
- Budget Reserved Usd
- 1.5
- Source Artifact Count
- 10